These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 24027432)
41. S100A4 negatively regulates β-catenin by inducing the Egr-1-PTEN-Akt-GSK3β degradation pathway. Yang W; Nam K; Ju JH; Lee KM; Oh S; Shin I Cell Signal; 2014 Oct; 26(10):2096-106. PubMed ID: 24975844 [TBL] [Abstract][Full Text] [Related]
42. COP1 Acts as a Ubiquitin Ligase for PCDH9 Ubiquitination and Degradation in Human Glioma. Zhou K; Wang L; Sun Z; Liu Y; Zhu Y; Liu Z; Zhang B; Shi H Mol Neurobiol; 2022 Apr; 59(4):2378-2388. PubMed ID: 35084653 [TBL] [Abstract][Full Text] [Related]
43. Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2, and its role in breast cancer progression. David D; Surendran A; Thulaseedharan JV; Nair AS BMC Cancer; 2018 Mar; 18(1):284. PubMed ID: 29534682 [TBL] [Abstract][Full Text] [Related]
44. A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function. Rottmann S; Wang Y; Nasoff M; Deveraux QL; Quon KC Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15195-200. PubMed ID: 16210249 [TBL] [Abstract][Full Text] [Related]
45. The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway. Salah Z; Itzhaki E; Aqeilan RI Oncotarget; 2014 Nov; 5(21):10886-900. PubMed ID: 25350971 [TBL] [Abstract][Full Text] [Related]
46. SCF Bai J; Wu K; Cao MH; Yang Y; Pan Y; Liu H; He Y; Itahana Y; Huang L; Zheng JN; Pan ZQ Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11754-11763. PubMed ID: 31138683 [TBL] [Abstract][Full Text] [Related]
47. The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Wei W; Jin J; Schlisio S; Harper JW; Kaelin WG Cancer Cell; 2005 Jul; 8(1):25-33. PubMed ID: 16023596 [TBL] [Abstract][Full Text] [Related]
48. An Arabidopsis SUMO E3 Ligase, SIZ1, Negatively Regulates Photomorphogenesis by Promoting COP1 Activity. Lin XL; Niu D; Hu ZL; Kim DH; Jin YH; Cai B; Liu P; Miura K; Yun DJ; Kim WY; Lin R; Jin JB PLoS Genet; 2016 Apr; 12(4):e1006016. PubMed ID: 27128446 [TBL] [Abstract][Full Text] [Related]
49. RNF115/BCA2 E3 ubiquitin ligase promotes breast cancer cell proliferation through targeting p21Waf1/Cip1 for ubiquitin-mediated degradation. Wang Z; Nie Z; Chen W; Zhou Z; Kong Q; Seth AK; Liu R; Chen C Neoplasia; 2013 Sep; 15(9):1028-35. PubMed ID: 24027428 [TBL] [Abstract][Full Text] [Related]
50. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Guo BH; Feng Y; Zhang R; Xu LH; Li MZ; Kung HF; Song LB; Zeng MS Mol Cancer; 2011 Jan; 10(1):10. PubMed ID: 21276221 [TBL] [Abstract][Full Text] [Related]
51. E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1. Li DQ; Ohshiro K; Reddy SD; Pakala SB; Lee MH; Zhang Y; Rayala SK; Kumar R Proc Natl Acad Sci U S A; 2009 Oct; 106(41):17493-8. PubMed ID: 19805145 [TBL] [Abstract][Full Text] [Related]
52. Identification of integrins alpha6 and beta7 as c-Jun- and transformation-relevant genes in highly invasive fibrosarcoma cells. Kielosto M; Nummela P; Järvinen K; Yin M; Hölttä E Int J Cancer; 2009 Sep; 125(5):1065-73. PubMed ID: 19405119 [TBL] [Abstract][Full Text] [Related]
53. Enhancement of paclitaxel-induced breast cancer cell death via the glycogen synthase kinase-3β-mediated B-cell lymphoma 2 regulation. Noh KT; Cha GS; Kang TH; Cho J; Jung ID; Kim KY; Ahn SC; You JC; Park YM BMB Rep; 2016 Jan; 49(1):51-6. PubMed ID: 26246283 [TBL] [Abstract][Full Text] [Related]
54. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage. Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761 [TBL] [Abstract][Full Text] [Related]
56. Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6. Tan Y; Ci Y; Dai X; Wu F; Guo J; Liu D; North BJ; Huo J; Zhang J Oncotarget; 2017 Jul; 8(29):47890-47901. PubMed ID: 28599312 [TBL] [Abstract][Full Text] [Related]